AI-infused drug developer Recursion Pharmaceuticals has hired Najat Khan, Ph.D., as chief commercial officer and head of R&D. She joins from Johnson & Johnson where she was chief data science officer ...
Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki ...
• Matthew Kinn, Recursion’s senior vice president, business development and corporate initiatives, was promoted to serve as chief business officer. • Lina Nilsson, PhD, Recursion’s senior vice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results